Overview

A Study to Evaluate the DDI of HSK7653 With Metformin

Status:
Completed
Trial end date:
2019-12-09
Target enrollment:
Participant gender:
Summary
This is a Phase 1, single center, open-label, single arm, drug-drug interaction study of HSK7653 and metformin in Healthy Subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Haisco Pharmaceutical Group Co., Ltd.
Treatments:
Metformin